Tsurusawa M - Search Results

1

Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.

Tsurusawa M, Niwa M, Katano N, Fujimoto T. Tsurusawa M, et al. Cancer Res. 1988 Aug 1;48(15):4288-93. Cancer Res. 1988. PMID: 3390825

2

Cell proliferation in childhood acute leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis.

Ito M, Tsurusawa M, Zha Z, Kawai S, Takasaki Y, Fujimoto T. Ito M, et al. Among authors: tsurusawa m. Cancer. 1992 Apr 15;69(8):2176-82. doi: 10.1002/1097-0142(19920415)69:8<2176::aid-cncr2820690827>3.0.co;2-7. Cancer. 1992. PMID: 1347483

3

Methotrexate cytotoxicity as related to irreversible S phase arrest in mouse L1210 leukemia cells.

Tsurusawa M, Niwa M, Katano N, Fujimoto T. Tsurusawa M, et al. Jpn J Cancer Res. 1990 Jan;81(1):85-90. doi: 10.1111/j.1349-7006.1990.tb02511.x. Jpn J Cancer Res. 1990. PMID: 2108951 Free PMC article.

4

Flow cytometric determination with bromodeoxyuridine/DNA assay of sensitivity of S-phase cells to cytosine arabinoside in childhood acute lymphoblastic leukemia.

Katano N, Tsurusawa M, Niwa M, Fujimoto T. Katano N, et al. Among authors: tsurusawa m. Am J Pediatr Hematol Oncol. 1989 Winter;11(4):411-6. Am J Pediatr Hematol Oncol. 1989. PMID: 2618975

5

Flow cytometric evidence for minimal residual disease and cytological heterogeneities in acute lymphoblastic leukemia with severe hypodiploidy.

Tsurusawa M, Kaneko Y, Katano N, Niwa M, Ito M, Fujimoto T. Tsurusawa M, et al. Am J Hematol. 1989 Sep;32(1):42-9. doi: 10.1002/ajh.2830320109. Am J Hematol. 1989. PMID: 2757002

6

Prognostic implication of cellular DNA content in acute lymphoblastic leukemia.

Tsurusawa M, Katano N, Kawai S, Fujimoto T, Maeda M. Tsurusawa M, et al. Am J Pediatr Hematol Oncol. 1988 Spring;10(1):75-80. doi: 10.1097/00043426-198821000-00013. Am J Pediatr Hematol Oncol. 1988. PMID: 2973255

7

Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry.

Tsurusawa M, Aoyama M, Saeki K, Fujimoto T. Tsurusawa M, et al. Leukemia. 1995 Nov;9(11):1921-5. Leukemia. 1995. PMID: 7475284

8

Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.

Tsurusawa M, Fujimoto T. Tsurusawa M, et al. Cytometry. 1995 Jun 1;20(2):146-53. doi: 10.1002/cyto.990200207. Cytometry. 1995. PMID: 7664625 Free article.

9

Differential induction of apoptosis on human lymphoblastic leukemia Nalm-6 and Molt-4 cells by various antitumor drugs.

Tsurusawa M, Saeki K, Fujimoto T. Tsurusawa M, et al. Int J Hematol. 1997 Jul;66(1):79-88. doi: 10.1016/s0925-5710(97)00583-5. Int J Hematol. 1997. PMID: 9220663

10

Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.

Tsurusawa M, Saeki K, Katano N, Fujimoto T. Tsurusawa M, et al. Pediatr Hematol Oncol. 1998 Mar-Apr;15(2):143-55. doi: 10.3109/08880019809167229. Pediatr Hematol Oncol. 1998. PMID: 9592841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters